1CP
IDXX icon

1015 Capital Partners’s Idexx Laboratories IDXX Stock Holding History

1015 Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58K Sell
3
-1
-25% -$561 ﹤0.01% 373
2026
Q1 		$2.25K Buy
4
+1
+33% +$641 ﹤0.01% 304
2025
Q4 		$2.03K Buy
+3
New +$2.04K ﹤0.01% 306

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

1015 Capital Partners's IDXX Position: Q2 2026 in Review

1015 Capital Partners reduced its Idexx Laboratories (IDXX) stake by 25% in Q2 2026, selling an estimated $561 and leaving 3 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #373.

1015 Capital Partners first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.25K in Q1 2026. 1,292 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • 1015 Capital Partners held 3 shares of Idexx Laboratories worth $1.58K as of Q2 2026.
  • 1015 Capital Partners sold 1 Idexx Laboratories share in Q2 2026, an estimated $561.
  • Idexx Laboratories made up ﹤0.01% of 1015 Capital Partners's portfolio in Q2 2026, its #373 holding.
  • 1015 Capital Partners first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 1015 Capital Partners's Idexx Laboratories position peaked at $2.25K in Q1 2026.
  • 1,292 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.